These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16255781)

  • 1. Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.
    Roudsari AH; Tahbaz F; Hossein-Nezhad A; Arjmandi B; Larijani B; Kimiagar SM
    Nutr J; 2005 Oct; 4():30. PubMed ID: 16255781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.
    Wangen KE; Duncan AM; Merz-Demlow BE; Xu X; Marcus R; Phipps WR; Kurzer MS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3043-8. PubMed ID: 10999783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kurzer MS; Mizuno S; Watanabe S; Ishimi Y
    Bone; 2010 Aug; 47(2):413-23. PubMed ID: 20452475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
    Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J
    Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
    Cosman F; Nieves J; Woelfert L; Shen V; Lindsay R
    J Bone Miner Res; 1998 Jun; 13(6):1051-5. PubMed ID: 9626638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
    Rejnmark L; Buus NH; Vestergaard P; Heickendorff L; Andreasen F; Larsen ML; Mosekilde L
    J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy isoflavones for osteoporosis: an evidence-based approach.
    Taku K; Melby MK; Nishi N; Omori T; Kurzer MS
    Maturitas; 2011 Dec; 70(4):333-8. PubMed ID: 21958941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women.
    Arjmandi BH; Lucas EA; Khalil DA; Devareddy L; Smith BJ; McDonald J; Arquitt AB; Payton ME; Mason C
    Nutr J; 2005 Feb; 4():8. PubMed ID: 15727682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A; Hannon RA; Eastell R
    J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring alendronate therapy for osteoporosis.
    Braga de Castro Machado A; Hannon R; Eastell R
    J Bone Miner Res; 1999 Apr; 14(4):602-8. PubMed ID: 10234582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of soy isoflavone intake on bone loss in menopausal women: evaluated by meta-analysis of randomized controlled trials].
    Ma D; Qin L; Liu B; Wang P
    Wei Sheng Yan Jiu; 2009 Sep; 38(5):546-51. PubMed ID: 19877511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML; Thomas JL; Bergougnoux L; Garnero P; Drapier-Faure E; Delmas PD
    Climacteric; 2005 Jun; 8(2):136-45. PubMed ID: 16096169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.